AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Net cash inflow from operating activities by Quarter
Net cash inflow from operating activities ($M) ($M)
AstraZeneca Net cash inflow from operating activities: $2,865M in Q2 2026, down 15.4% from a year earlier.
Where the Q2 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
Source: Form 6-K FY2026Q2 Earnings Release ↗
Reported in Form 6-K Quarterly (period-split Q1–Q4) & Form 20-F Cash Flow Statement.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up net cash inflow from operating activities
- Net cash inflow before financing activities ($M)-47 · Q2 2026
- Movement in working capital & short-term provisions ($M)-438 · Q2 2026
- Income tax paid ($M)-1,525 · Q2 2026
- Interest paid ($M)-189 · Q2 2026
- Purchase of property, plant and equipment (Capex) ($M)-763 · Q2 2026
- Purchase of intangible assets ($M)-2,342 · Q2 2026
- Dividends paid to shareholders ($M)-1 · Q2 2026
Cite this data
StockData. (2026). AstraZeneca Net cash inflow from operating activities ($M), quarterly Q1 2021–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/cf-operating
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.